- VC-style research lens applied to public markets
- Inception: 06/30/2005
- Rebalance: Quarterly
- Approx. turnover: ~15–20% (approx.)
- Calculated by: Refinitiv (LSEG)
| Type Index |
| Inception Date 06/30/2005 |
ER30TR applies a venture-capital lens to public markets, built on 20+ years of research. The proprietary Entrepreneur Factor® framework evaluates companies across 18 proprietary attributes designed to surface entrepreneurial leadership and innovation characteristics. The index is rules-based and rebalanced quarterly to maintain disciplined exposure over time.
As of: 03.31.2026
| Index Performance Chart As of 03/31/2026 |
| NAV | $- |
| Market Price | $- |
| Information Technology 38.75% |
| Health Care 18.10% |
| Communication Services 16.47% |
| Financials 13.85% |
| Consumer Discretionary 6.79% |
| Industrials 6.04% |
Sector Allocations are subject to change
* All performance figures shown are annualized.
The ERShares ER30TR Index selects the most entrepreneurial, primarily US Large Cap companies, that meet the threshold embedded in the proprietary Entrepreneur Factor® (EF). It is not possible to invest directly in the Index, and past performance does not guarantee future results. Investors should conduct their own research and consider the risks associated with any investments linked to the Index.
Disclosures
ER30TR Index Disclosure:
The ERShares ER30TR Index selects the most entrepreneurial, primarily US Large Cap companies, that meet the threshold embedded in the proprietary Entrepreneur Factor® (EF). It is not possible to invest directly in the Index, and past performance does not guarantee future results. Investors should conduct their own research and consider the risks associated with any investments linked to the Index.
We are sharing an update on XOVR's SpaceX exposure, performance, and four stages of innovation during the SpaceX IPO period.
From March 30 through June 15, 2026, XOVR's SpaceX exposure reflected more than $183 million of unrealized appreciation, including appreciation associated with SpaceX's IPO and commencement of public trading on NASDAQ on June 12, 2026.
Over the same period, XOVR appreciated approximately 30.71%, with SpaceX exposure contributing significantly to ETF performance.
The update also highlights four XOVR innovations: the private-public crossover ETF structure, the 0/0 SPV structure, a first-of-its-kind liquidity arrangement, and the Shareholder Protection Plan designed to prioritize existing long-term shareholders during the SpaceX IPO period.
Subscribe to our newsletter to stay updated about the global markets.